Showing results (51-60 of 139) with videos related to

Sort By:
Pageof 14
Current Pharmaceutical Design|September 12, 2017
A Special Focus on Selexipag - Treatment of Pulmonary Arterial HypertensionLouise M Sorensen, Markus Wehland, Marcus Kruger, et al.
International Journal of Molecular Sciences|September 25, 2019
Drug-Induced Hypertension Caused by Multikinase Inhibitors (Sorafenib, Sunitinib, Lenvatinib and Axitinib) in Renal Cell Carcinoma TreatmentNanna Bæk Møller, Cecilie Budolfsen, Daniela Grimm, et al.
Seminars in Cancer Biology|March 28, 2019
The role of SOX family members in solid tumours and metastasisDaniela Grimm, Johann Bauer, Petra Wise, et al.
Polski Przeglad Chirurgiczny|July 18, 2018
Surgical teaching at the Medical School Otto-von-Guericke University of Magdeburg - basic conceptual descriptionArmin Kraus, Manfred Infanger, Costanza Chiapponi, et al.
Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology|July 23, 2013
Impact of sunitinib on human thyroid cancer cellsJirka Grosse, Elisabeth Warnke, Fabian Pohl, et al.
Current Vascular Pharmacology|February 2, 2019
Tyrosine Kinase Inhibitor-Induced Hypertension: Role of Hypertension as a Biomarker in Cancer TreatmentCecilie Budolfsen, Julie Faber, Daniela Grimm, et al.
International Journal of Molecular Sciences|October 24, 2018
Pazopanib, Cabozantinib, and Vandetanib in the Treatment of Progressive Medullary Thyroid Cancer with a Special Focus on the Adverse Effects on HypertensionRikke Vilsbøll Milling, Daniela Grimm, Marcus Krüger, et al.
Plos One|November 19, 2013
Changes in morphology, gene expression and protein content in chondrocytes cultured on a random positioning machineGanna Aleshcheva, Jayashree Sahana, Xiao Ma, et al.
Pageof 14